Postbiotic driven immunomodulation: SCFAs as therapeutic agents in rheumatoid arthritis. Journal of Current Biomedical Reports, [S. l.], v. 4, n. 4, p. 141–142, 2023. DOI: 10.61882/jcbior.4.4.292. Disponível em: https://mail.jcbior.com/index.php/JCBioR/article/view/292. Acesso em: 6 jun. 2026.